These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16447247)

  • 21. Spondyloarthritis research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis.
    Maksymowych WP; Inman RD; Salonen D; Dhillon SS; Williams M; Stone M; Conner-Spady B; Palsat J; Lambert RG
    Arthritis Rheum; 2005 Oct; 53(5):703-9. PubMed ID: 16208659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computed tomography guided intra-articular injection of etanercept in the sacroiliac joint is an effective mode of treatment of ankylosing spondylitis.
    Cui Y; Xiao Z; Shuxia W; Zhenjun Z; Hengguo Z; Liangyi F; Weicheng G; Li L; Guangfeng Z; Yunzhen S; Guangfu D
    Scand J Rheumatol; 2010 May; 39(3):229-32. PubMed ID: 20109079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraarticular injection of infliximab.
    Sakellariou GT; Kakavouli G; Chatzigiannis I
    J Rheumatol; 2006 Sep; 33(9):1912-3; author reply 1913. PubMed ID: 16960955
    [No Abstract]   [Full Text] [Related]  

  • 24. Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab.
    van der Heijde D; Breban M; Halter D; DiVittorio G; Bratt J; Cantini F; Kary S; Pangan AL; Kupper H; Rathmann SS; Sieper J; Mease PJ
    Rheumatology (Oxford); 2015 Jul; 54(7):1210-9. PubMed ID: 25541333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks.
    Davis JC; van der Heijde DM; Braun J; Dougados M; Cush J; Clegg D; Inman RD; Kivitz A; Zhou L; Solinger A; Tsuji W
    Ann Rheum Dis; 2005 Nov; 64(11):1557-62. PubMed ID: 15843448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic controversies: tumor necrosis factor α inhibitors in ankylosing spondylitis.
    Song IH; Maksymowych WP
    Rheum Dis Clin North Am; 2012 Aug; 38(3):613-33. PubMed ID: 23083759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
    Furst DE; Schiff MH; Fleischmann RM; Strand V; Birbara CA; Compagnone D; Fischkoff SA; Chartash EK
    J Rheumatol; 2003 Dec; 30(12):2563-71. PubMed ID: 14719195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of anakinra in active ankylosing spondylitis: a clinical and magnetic resonance imaging study.
    Tan AL; Marzo-Ortega H; O'Connor P; Fraser A; Emery P; McGonagle D
    Ann Rheum Dis; 2004 Sep; 63(9):1041-5. PubMed ID: 15066864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab.
    Sieper J; Baraliakos X; Listing J; Brandt J; Haibel H; Rudwaleit M; Braun J
    Rheumatology (Oxford); 2005 Dec; 44(12):1525-30. PubMed ID: 16091396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging in ankylosing spondylitis.
    Zochling J; Baraliakos X; Hermann KG; Braun J
    Curr Opin Rheumatol; 2007 Jul; 19(4):346-52. PubMed ID: 17551364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment.
    Lukas C; Braun J; van der Heijde D; Hermann KG; Rudwaleit M; Østergaard M; Oostveen A; O'Connor P; Maksymowych WP; Lambert RG; Jurik AG; Baraliakos X; Landewé R;
    J Rheumatol; 2007 Apr; 34(4):862-70. PubMed ID: 17407241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adalimumab is effective and well tolerated in treating patients with ankylosing spondylitis who have advanced spinal fusion.
    Rudwaleit M; Olivieri I; Boki KA; Griep EN; Järvinen P; Wong RL; Kron M; Kary S; Kupper H
    Rheumatology (Oxford); 2009 May; 48(5):551-7. PubMed ID: 19254918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation.
    de Vries MK; Brouwer E; van der Horst-Bruinsma IE; Spoorenberg A; van Denderen JC; Jamnitski A; Nurmohamed MT; Dijkmans BA; Aarden LA; Wolbink GJ
    Ann Rheum Dis; 2009 Nov; 68(11):1787-8. PubMed ID: 19822712
    [No Abstract]   [Full Text] [Related]  

  • 34. A double-blind, placebo-controlled trial of low dose infliximab in ankylosing spondylitis.
    Inman RD; Maksymowych WP;
    J Rheumatol; 2010 Jun; 37(6):1203-10. PubMed ID: 20231198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor-α inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in China.
    Xu M; Lin Z; Deng X; Li L; Wei Y; Liao Z; Li Q; Wei Q; Hu Z; Zhang Y; Lin Q; Huang J; Li T; Pan Y; Wu Y; Jin O; Yu B; Gu J
    Rheumatology (Oxford); 2011 Aug; 50(8):1466-72. PubMed ID: 21441550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study.
    Davis JC; Revicki D; van der Heijde DM; Rentz AM; Wong RL; Kupper H; Luo MP
    Arthritis Rheum; 2007 Aug; 57(6):1050-7. PubMed ID: 17665483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human leukocyte antigen-G in ankylosing spondylitis and the response after tumour necrosis factor-alpha blocker therapy.
    Chen CH; Liao HT; Chen HA; Liu CH; Liang TH; Wang CT; Tsai CY; Chou CT
    Rheumatology (Oxford); 2010 Feb; 49(2):264-70. PubMed ID: 20008091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New therapeutic approaches for spondyloarthritis.
    Manadan AM; James N; Block JA
    Curr Opin Rheumatol; 2007 May; 19(3):259-64. PubMed ID: 17414952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS).
    Revicki DA; Luo MP; Wordsworth P; Wong RL; Chen N; Davis JC;
    J Rheumatol; 2008 Jul; 35(7):1346-53. PubMed ID: 18484692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of incentive spirometer exercise on pulmonary functions of patients with ankylosing spondylitis stabilized by tumor necrosis factor inhibitor therapy.
    So MW; Heo HM; Koo BS; Kim YG; Lee CK; Yoo B
    J Rheumatol; 2012 Sep; 39(9):1854-8. PubMed ID: 22859343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.